Company Achillion Pharmaceuticals, Inc.
Equities
US00448Q2012
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 20-01-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 20-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,046,647 | 139,814,104 ( 99.83 %) | 0 | 99.83 % |
Company contact information
Achillion Pharmaceuticals, Inc.
1777 Sentry Parkway West Building 14, Suite 200
19422, Blue Bell
+215-709-3040
http://www.achillion.comSector
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |